Mast Cell Activation Syndrome (MCAS): The Underdiagnosed Allergic-Autonomic Condition
Mast cell activation syndrome (MCAS) is a condition in which mast cells — immune cells that mediate allergic responses — are not numerically increased (as they are in mastocytosis) but are inappropriately activated, releasing histamine, tryptase, leukotrienes, prostaglandins, and dozens of other mediators in response to triggers that should not provoke them. The result is a multi-system illness that affects skin, gastrointestinal tract, cardiovascular and respiratory systems, and nervous system. MCAS is often triggered or unmasked by infections (including EBV and COVID-19), physical trauma, pregnancy, or hormonal transitions, and it clusters heavily with POTS and ME/CFS.
Table of Contents
- What MCAS Is
- Multi-System Symptoms
- Diagnostic Criteria
- Common Triggers
- Workup
- Treatment — The Stepped Approach
- Low-Histamine Diet
- Overlap with POTS, ME/CFS, and EDS
- Connections
What MCAS Is
Mast cells normally release their granule contents only in response to specific allergen-IgE binding or genuine pathogen signals. In MCAS, they degranulate repeatedly in response to non-immunologic triggers — heat, cold, stress, friction, certain foods, certain medications, exercise, and even emotional stimuli. The downstream effects cascade across systems because mast cells sit at tissue interfaces throughout the body — skin, gut mucosa, blood-vessel walls, respiratory tract, and perivascular nervous tissue.
Multi-System Symptoms
Symptoms typically span at least two organ systems and fluctuate:
- Skin: flushing, hives, itching, dermographism (skin writing), angioedema
- Gastrointestinal: abdominal pain, diarrhea, nausea, reflux, bloating, food sensitivities
- Cardiovascular: palpitations, lightheadedness, syncope, blood-pressure instability
- Respiratory: nasal congestion, postnasal drip, wheezing, throat tightness
- Neurologic: headache, brain fog, anxiety, insomnia
- Musculoskeletal: bone and joint pain, muscle aches
- Systemic: anaphylaxis, fatigue, chemical/scent sensitivity
Diagnostic Criteria
Consensus criteria require all three:
- Episodic symptoms consistent with mast-cell mediator release affecting at least two organ systems.
- Objective evidence of mast-cell mediator release — elevated serum tryptase measured during or within 4 hours of a symptomatic episode, or elevated 24-hour urinary n-methyl-histamine, prostaglandin D2 metabolite, or leukotriene E4.
- Response to mast-cell-directed therapy.
In practice, mediator measurement is often falsely negative because labs are typically drawn between flares. The clinical picture and therapeutic response are often the most meaningful signals.
Common Triggers
- Alcohol, aged/fermented foods, histamine-rich foods
- Temperature extremes, hot showers, sun exposure
- Physical pressure, vibration, friction
- NSAIDs, opioids, radiocontrast, certain antibiotics
- Strong scents, chemicals, mold
- Stress, including emotional
- Exercise
- Hormonal fluctuation (menstrual, pregnancy, menopause)
- Infections — viral and bacterial
Workup
- Serum tryptase (baseline and during flare) — >20% rise above baseline + 2 ng/mL during flare is highly suggestive.
- 24-hour urinary n-methyl-histamine, prostaglandin D2 metabolite, leukotriene E4 (chilled transport).
- Total and specific IgE, allergy evaluation.
- KIT D816V mutation analysis to exclude systemic mastocytosis.
- Evaluation for POTS, EDS/hypermobility, and autoimmune overlap.
Treatment — The Stepped Approach
- H1 antihistamines — cetirizine, loratadine, fexofenadine at standard doses, titrating upward as needed (sometimes 2–4x standard).
- H2 antihistamines — famotidine, added to H1.
- Mast-cell stabilizers — cromolyn sodium oral solution before meals, ketotifen.
- Leukotriene inhibitors — montelukast, zafirlukast.
- Quercetin as a natural mast-cell stabilizer (see Quercetin).
- Vitamin C — aids quercetin recycling and has some antihistamine effect.
- Aspirin at low dose for flushing (only with tolerance confirmed).
- Omalizumab for severe refractory cases.
- Emergency epinephrine for patients with history of anaphylaxis.
Low-Histamine Diet
Short-term (2–4 weeks) elimination of high-histamine and histamine-releasing foods often reveals how large a contribution diet is making. Avoid: aged cheeses, cured meats, fermented foods (kimchi, sauerkraut, kombucha), alcohol, vinegar-containing products, tomatoes, spinach, eggplant, citrus, avocado, nuts, shellfish, and leftovers more than 24 hours old. Favor freshly prepared, fresh meats, non-citrus fruits, rice, gluten-free grains. Low-histamine diet is a diagnostic and symptom-management tool, not a lifelong sentence — reintroduction under control is part of the protocol.
Overlap with POTS, ME/CFS, and EDS
MCAS, POTS, and Ehlers-Danlos syndrome / hypermobility spectrum disorder form the classic “triad.” ME/CFS sits adjacent. Screening for the other members of the cluster when one is diagnosed is now standard practice. Proposed shared mechanisms include mast-cell–autonomic interactions in perivascular tissue, connective-tissue fragility affecting autonomic ganglia, and shared post-infectious pathophysiology.